These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11986127)

  • 1. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease.
    Mentis MJ; McIntosh AR; Perrine K; Dhawan V; Berlin B; Feigin A; Edwards C; Mattis P; Eidelberg D
    Am J Psychiatry; 2002 May; 159(5):746-54. PubMed ID: 11986127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.
    Bohnen NI; Müller ML; Kotagal V; Koeppe RA; Kilbourn MA; Albin RL; Frey KA
    Brain; 2010 Jun; 133(Pt 6):1747-54. PubMed ID: 20413575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual hallucination in Parkinson's disease with FDG PET.
    Nagano-Saito A; Washimi Y; Arahata Y; Iwai K; Kawatsu S; Ito K; Nakamura A; Abe Y; Yamada T; Kato T; Kachi T
    Mov Disord; 2004 Jul; 19(7):801-806. PubMed ID: 15254938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
    Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K
    Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
    Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
    Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study.
    Huang C; Ravdin LD; Nirenberg MJ; Piboolnurak P; Severt L; Maniscalco JS; Solnes L; Dorfman BJ; Henchcliffe C
    Dement Geriatr Cogn Disord; 2013; 35(3-4):183-96. PubMed ID: 23445555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic brain networks associated with cognitive function in Parkinson's disease.
    Huang C; Mattis P; Tang C; Perrine K; Carbon M; Eidelberg D
    Neuroimage; 2007 Jan; 34(2):714-23. PubMed ID: 17113310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing.
    Moeller JR; Eidelberg D
    Brain; 1997 Dec; 120 ( Pt 12)():2197-206. PubMed ID: 9448575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease.
    van der Zee S; Müller MLTM; Kanel P; van Laar T; Bohnen NI
    Mov Disord; 2021 Mar; 36(3):642-650. PubMed ID: 33137238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.
    Specketer K; Zabetian CP; Edwards KL; Tian L; Quinn JF; Peterson-Hiller AL; Chung KA; Hu SC; Montine TJ; Cholerton BA
    J Clin Exp Neuropsychol; 2019 Oct; 41(8):803-813. PubMed ID: 31177941
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolic topography of parkinsonism.
    Eidelberg D; Moeller JR; Dhawan V; Spetsieris P; Takikawa S; Ishikawa T; Chaly T; Robeson W; Margouleff D; Przedborski S
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):783-801. PubMed ID: 8063874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography metabolic correlates of apathy in Alzheimer disease.
    Marshall GA; Monserratt L; Harwood D; Mandelkern M; Cummings JL; Sultzer DL
    Arch Neurol; 2007 Jul; 64(7):1015-20. PubMed ID: 17620493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease.
    Filoteo JV; Reed JD; Litvan I; Harrington DL
    Mov Disord; 2014 Mar; 29(3):360-7. PubMed ID: 24038502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of intellectual impairment in Parkinson's disease with FDG PET scan.
    Wu JC; Iacono R; Ayman M; Salmon E; Lin SD; Carlson J; Keator D; Lee A; Najafi A; Fallon J
    Neuroreport; 2000 Jul; 11(10):2139-44. PubMed ID: 10923659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Brain Correlations of Visuospatial and Visuoperceptual Tests in Parkinson's Disease.
    Garcia-Diaz AI; Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Uribe C; Campabadal A; Abos A; Junque C
    J Int Neuropsychol Soc; 2018 Jan; 24(1):33-44. PubMed ID: 28714429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease.
    Funkiewiez A; Ardouin C; Caputo E; Krack P; Fraix V; Klinger H; Chabardes S; Foote K; Benabid AL; Pollak P
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):834-9. PubMed ID: 15145995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.